Advanced Therapies Inc.
Questions?
Please contact Sales at: (212) 520-2765 or email [email protected]
Latest From Advanced Therapies Inc.
EU publishes Regulation on advanced therapies certification
An EU Regulation intended to encourage research into advanced therapies by micro, small and medium-size enterprises (SMEs) has been published in the Official Journal and is expected to enter force next week.
AIFA's new board takes its seats in Italy
The Italian government said that its reorganisation of AIFA, the national medicines regulatory agency, is nearly complete as a new board of directors was installed yesterday.
Spain to ease clinical trials of advanced therapies
Independent researchers and researchers investigating advanced therapies in Spain should find it easier to gain approval for clinical trials thanks to a new support office, says the health ministry.
Good news for advanced therapies, bad news for an old painkiller
It's been a busy week for the European Medicines Agency. Not only has it recommended marketing approval of the first advanced therapy product under the new regulatory framework, it has also finally decided that all drugs containing the opioid painkiller dextropropoxyphene should be withdrawn for safety reasons.
Company Information
- Industry
- Biotechnology
-
Pharmaceuticals
- Drug Delivery
- Other Names / Subsidiaries
-
- ADVANCED THERAPIES, INC.
You must sign in to use this functionality
Authentication.SignIn.HeadSignInHeader
Email Company
All set! This article has been sent to my@email.address.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
DCD.EmailPopout.Notice